Oaktree Acquisition Corp. III Life Sciences — Form 10-Q
Filed August 12, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
Zaid Pardesi (CEO) and George A. Martinez (CFO) signed standard Sarbanes-Oxley certifications dated August 12, 2026 for the quarter ended June 30, 2026. Both officers certified that the 10-Q contains no untrue material statements, that financial statements fairly present the company's condition and cash flows, and that disclosure controls and internal control over financial reporting are effective. No significant deficiencies, material weaknesses, or fraud were disclosed.
Why this rating
Routine SOX certification exhibits; no operational, financial, or strategic content disclosed; standard boilerplate disclosure requirement.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.